【US Stock Market Movement】Twist Bioscience plunges on October 6: ARK reduces holdings + high valuation pressure
Bitget异动解读2026/10/06 14:25Interpretation of Twist Bioscience's Sharp Drop on October 6
Keywords: ARK reduction, high valuation pressure
1. On October 6, 2026, funds under Ark Invest sold approximately 90,700 shares of Twist Bioscience, amounting to about $18 million. The adjustment in holdings has increased the supply pressure of the stock.
2. On October 6, 2026, TWST had risen 500.60% cumulatively this year, with its stock price far exceeding the valuation and target prices of some institutions. The company is still operating at a loss, and under a high valuation background, the pressure for profit-taking has increased.
(Disclaimer: This content is collected and summarized from public information by AI technology for reference only, and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EIA expects Middle Eastern oil production and exports through the Strait of Hormuz to gradually increase
U.S. Energy Information Administration (EIA): Middle Eastern oil production and exports through the Strait of Hormuz are expected to "gradually increase" due to facilitated transit.
EIA forecasts that oil production shutdowns will drop to 2.7 million barrels per day in the first quarter of 2027
U.S. Energy Information Administration (EIA): As alternative transportation options expand, the projected oil production shutdown in Q1 2027 is expected to decrease to 2.7 million barrels per day from 4.5 million barrels per day in Q4 2026.
Google launches Embedding Gemma2 multimodal embedding model
Google (GOOG.US): Launches Embedding Gemma2, a multimodal embedding model.
Marvell Technology CFO expects non-GAAP earnings per share to exceed $30 in fiscal year 2031
Marvell Technology Group (MRVL.US) CFO: We expect non-GAAP earnings per share to exceed $30 in fiscal year 2031.
Crypto prices
More
